ConductScience.org, home

Paper3098151

High-dose busulfan and myoclonic epilepsy.

Martell RW and 3 others. Ann Intern Med, 1987. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. High-dose busulfan and myoclonic epilepsy. Papers, record 3098151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3098151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High-dose busulfan and myoclonic epilepsy.
PubMed
Journal
Ann Intern Med
PubMed
Year
1987
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.21
iCite
Revised in PubMed
2019-06-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martell RWR W
2Sher CC
3Jacobs PP
4Monteagudo FF

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BusulfanMajor topic
Epilepsies, MyoclonicMajor topic
Adult
Bone Marrow Transplantation
Female
Humans
Leukemia, Myeloid, Acute

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
19361744Busulfan in hematopoietic stem cell transplantation.Biol Blood Marrow Transplant2009https://conductscience.org/library/papers/19361744PubMed
10523796The role of busulfan in bone marrow transplantation.Med Oncol1999https://conductscience.org/library/papers/10523796PubMed
8847558Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients.J Neurooncol1996https://conductscience.org/library/papers/8847558PubMed
8269597Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8269597PubMed
2265459The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2265459PubMed
2182049Clinical features, pathogenesis and management of drug-induced seizures.Drug Saf1990https://conductscience.org/library/papers/2182049PubMed
1600599In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1600599PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3098151

GET https://conductscience.org/api/papers/v1/3098151/authors